-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cj0Pg8qA1Hl167eA990pCjQ0yUUDxpBZpK7Vqljc99PXRhMhmIoIG+MtdS1DMm1p qJHtBTJbtAmCvheTsLsiZg== 0001209191-06-061663.txt : 20061128 0001209191-06-061663.hdr.sgml : 20061128 20061128170145 ACCESSION NUMBER: 0001209191-06-061663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061127 FILED AS OF DATE: 20061128 DATE AS OF CHANGE: 20061128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11011 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195508500 MAIL ADDRESS: STREET 1: 11011 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MULLEN JAMES C CENTRAL INDEX KEY: 0001226288 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 061242770 BUSINESS ADDRESS: BUSINESS PHONE: 6176792000 MAIL ADDRESS: STREET 1: BIOGEN INC LEGAL DEPARTMENT STREET 2: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2006-11-27 0 0000875045 BIOGEN IDEC INC BIIB 0001226288 MULLEN JAMES C 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 1 1 0 0 CEO & President Common Stock 2006-11-27 4 M 0 12500 36.09 A 106752 D Common Stock 2006-11-27 4 S 0 12500 50.9869 D 94252 D Stock Option (right-to-buy) 36.09 2006-11-27 4 M 0 12500 D 2009-01-04 Common Stock 12500 0 D Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d). The stock option became exercisable in five (5) equal annual installments, commencing one year after the grant date of 01/04/99. By: Kevin Foley; For: James C. Mullen 2006-11-28 -----END PRIVACY-ENHANCED MESSAGE-----